Startoon Labs Partners With Medplus To Launch Pheezee Muscle & Joint Health Diagnostics
Apr 7, 2025


Source: Pharmabiz
Share:
Hyderabad-based medical device innovator Startoon Labs has signed an MoU with Medplus, a leading pharmacy retail chain, to launch its AI-powered joint and muscle diagnostic tool, Pheezee, at Medplus diagnostic centres. This marks a significant leap in accessible muscle and joint healthcare for Indian patients.
Key Highlights
MoU Signed Between Startoon Labs & Medplus
Pheezee, a wearable diagnostic device developed by Startoon Labs, will now be available at Medplus diagnostic centres.
The device is listed with the US FDA and designed to assess muscle and nerve function in patients with joint and musculoskeletal pain.
Pheezee Offers AI-Based Diagnostic Reports
The device provides AI-generated, physiotherapy-focused diagnostic reports.
Helps identify the root cause of pain by pinpointing the affected muscle, allowing targeted treatment.
Offers a non-invasive alternative to traditional imaging tests like X-ray, MRI, and CT scans.
Addresses India's Growing Joint Pain Burden
Nearly 50% of Indians aged 45+ report joint pain; 64.9% of IT professionals experience neck pain.
Pheezee targets conditions like arthritis, muscular dystrophy, carpal tunnel syndrome, and nerve disorders.
Expanding Access To Underserved Patients
Pheezee improves diagnosis for patients with limited access to advanced healthcare.
Also used by clients like TGSRTC to assess drivers’ pain and boost efficiency.
Statements from Leaders or Officials
Suresh Susurla, CEO & Co-founder, Startoon Labs:
“Pheezee adds critical diagnostic information that imaging tools miss. It enhances orthopaedic and neurological decision-making.”
Dr. Srivani, Physiotherapist:
“It enables precise evaluation of muscle function and nerve communication—essential for joint and muscle pain recovery.”
Mythreyi Kondapi, CTO & Co-founder, Startoon Labs:
“Bringing Pheezee to Medplus is a game-changer in diagnostics. It helps catch early-stage musculoskeletal issues and ensures better rehab outcomes.”This collaboration strengthens India’s digital MedTech innovation landscape. As part of the $15.35 billion Indian MedTech industry, Startoon Labs contributes to a growing push toward smart, AI-enabled healthcare.
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved


Source: Pharmabiz
Hyderabad-based medical device innovator Startoon Labs has signed an MoU with Medplus, a leading pharmacy retail chain, to launch its AI-powered joint and muscle diagnostic tool, Pheezee, at Medplus diagnostic centres. This marks a significant leap in accessible muscle and joint healthcare for Indian patients.
Key Highlights
MoU Signed Between Startoon Labs & Medplus
Pheezee, a wearable diagnostic device developed by Startoon Labs, will now be available at Medplus diagnostic centres.
The device is listed with the US FDA and designed to assess muscle and nerve function in patients with joint and musculoskeletal pain.
Pheezee Offers AI-Based Diagnostic Reports
The device provides AI-generated, physiotherapy-focused diagnostic reports.
Helps identify the root cause of pain by pinpointing the affected muscle, allowing targeted treatment.
Offers a non-invasive alternative to traditional imaging tests like X-ray, MRI, and CT scans.
Addresses India's Growing Joint Pain Burden
Nearly 50% of Indians aged 45+ report joint pain; 64.9% of IT professionals experience neck pain.
Pheezee targets conditions like arthritis, muscular dystrophy, carpal tunnel syndrome, and nerve disorders.
Expanding Access To Underserved Patients
Pheezee improves diagnosis for patients with limited access to advanced healthcare.
Also used by clients like TGSRTC to assess drivers’ pain and boost efficiency.
Statements from Leaders or Officials
Suresh Susurla, CEO & Co-founder, Startoon Labs:
“Pheezee adds critical diagnostic information that imaging tools miss. It enhances orthopaedic and neurological decision-making.”
Dr. Srivani, Physiotherapist:
“It enables precise evaluation of muscle function and nerve communication—essential for joint and muscle pain recovery.”
Mythreyi Kondapi, CTO & Co-founder, Startoon Labs:
“Bringing Pheezee to Medplus is a game-changer in diagnostics. It helps catch early-stage musculoskeletal issues and ensures better rehab outcomes.”This collaboration strengthens India’s digital MedTech innovation landscape. As part of the $15.35 billion Indian MedTech industry, Startoon Labs contributes to a growing push toward smart, AI-enabled healthcare.
Share:
Read Next
Read Next
Copyright © 2024 Pharmacy Pro. All rights reserved
Copyright © 2024 Pharmacy Pro. All rights reserved